Basis for immunotherapy for treatment of meningiomas

T Garzon-Muvdi, DD Bailey, MN Pernik… - Frontiers in neurology, 2020 - frontiersin.org
Meningiomas are common tumors that account for approximately one third of CNS tumors
diagnosed every year. They are classified by the World Health Organization in grades I-III …

DNA methylation meningioma biomarkers: attributes and limitations

Z Li, Y Gao, J Zhang, L Han, H Zhao - Frontiers in Molecular …, 2023 - frontiersin.org
Meningioma, one of the most common primary central nervous system tumors, are classified
into three grades by the World Health Organization (WHO) based on histopathology. The …

Prognostic value of histopathological features and loss of H3K27me3 immunolabeling in anaplastic meningioma: a multicenter retrospective study

G Gauchotte, M Peyre, C Pouget… - … of Neuropathology & …, 2020 - academic.oup.com
The diagnosis of anaplastic meningioma (AM)(WHO grade III) is based on the presence of a
high mitotic index (MI) and/or overt anaplasia. Only few data exist about the reproducibility …

Bioactivity and safety of B7‐H3‐targeted chimeric antigen receptor T cells against anaplastic meningioma

X Tang, F Liu, Z Liu, Y Cao, Z Zhang… - Clinical & …, 2020 - Wiley Online Library
Objective We conducted a first‐in‐human study to evaluate the bioactivity and safety of B7‐
H3‐targeted chimeric antigen receptor (CAR) autologous T cells for treating recurrent …

Incidence and survival of benign, borderline, and malignant meningioma patients in the United States from 2004 to 2018

J Cao, W Yan, G Li, Z Zhan, X Hong… - International Journal of …, 2022 - Wiley Online Library
Meningioma is the most common primary central nervous system tumor, and its incidence is
increasing. A systematic epidemiological and clinical analysis is required to better estimate …

Malignant meningioma: an international multicentre retrospective study

C Champeaux, V Jecko, D Houston, L Thorne… - …, 2019 - journals.lww.com
Malignant Meningioma: An International Multicentre Retrospec... : Neurosurgery Malignant
Meningioma: An International Multicentre Retrospective Study : Neurosurgery …

Individual-patient prediction of meningioma malignancy and survival using the Surveillance, Epidemiology, and End Results database

JT Moreau, TC Hankinson, S Baillet… - NPJ digital medicine, 2020 - nature.com
Meningiomas are known to have relatively lower aggressiveness and better outcomes than
other central nervous system (CNS) tumors. However, there is considerable overlap …

Associations of race and socioeconomic status with outcomes after intracranial meningioma resection: a systematic review and meta-analysis

H Lei, JK Tabor, J O'Brien, R Qin, AF Pappajohn… - Journal of Neuro …, 2023 - Springer
Purpose Social determinants of health broadly affect healthcare access and outcomes.
Studies report that minorities and low socioeconomic status (SES) patients undergoing …

Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas

D Li, P Jiang, S Xu, C Li, S Xi, J Zhang, Y Chen… - Journal of Neuro …, 2019 - Springer
Purpose We aim to investigate the impacts of extent of resection and adjuvant radiotherapy
on survival of high-grade meningiomas (WHO grade II–III) according to modern diagnosis …

Diagnostic and therapeutic strategy in anaplastic (malignant) meningioma, CNS WHO grade 3

V Di Nunno, C Giannini, S Asioli, A Conti, J Furtner… - Cancers, 2022 - mdpi.com
Simple Summary Only 1% of all meningioma diagnosis is classified as malignant
(anaplastic) meningioma. Due to their rarity, clinical management of these tumors presents …